OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural and bioinspired excipients for dry powder inhalation formulations
Daan Zillen, Max Beugeling, Wouter L.J. Hinrichs, et al.
Current Opinion in Colloid & Interface Science (2021) Vol. 56, pp. 101497-101497
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Recent developments in lactose blend formulations for carrier-based dry powder inhalation
Gerald A. Hebbink, Maarten Jaspers, Harry Peters, et al.
Advanced Drug Delivery Reviews (2022) Vol. 189, pp. 114527-114527
Closed Access | Times Cited: 52

Liposomes or Extracellular Vesicles: A Comprehensive Comparison of Both Lipid Bilayer Vesicles for Pulmonary Drug Delivery
Ali Al-Jipouri, Samah Hamed Almurisi, Khater AL-Japairai, et al.
Polymers (2023) Vol. 15, Iss. 2, pp. 318-318
Open Access | Times Cited: 31

Optimization of Carrier-Based Dry Powder Inhaler Performance: A Review
Tanu Mehta, Saeed Najafian, K. R. Patel, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 96-96
Open Access | Times Cited: 1

Impact of Co-Spray Drying with Leucine or Trileucine on Aerosol Performance, In Vitro Dissolution, and Cellular Uptake of Colistin Powder Formulations for Inhalation
Yu-Ting Huang, Kinnari Santosh Arte, Chanakya Patil, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 199-199
Open Access | Times Cited: 1

Preparation and Characterization of Ibuprofen Containing Nano-Embedded-Microparticles for Pulmonary Delivery
Petra Party, Márk László Klement, Piroska Szabó‐Révész, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 545-545
Open Access | Times Cited: 17

A review on micro and nanoengineering in Powder-Based pulmonary drug delivery
L. Paséro, Francesca Susa, Tania Limongi, et al.
International Journal of Pharmaceutics (2024) Vol. 659, pp. 124248-124248
Open Access | Times Cited: 6

Prospects of Inhaled Phage Therapy for Combatting Pulmonary Infections
Xiang Wang, Zuozhou Xie, Jinhong Zhao, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 38

Development and characterization of nintedanib inhalable powders as a potential pulmonary fibrosis treatment
Valentina Ruggiero, Giovanna Aquino, Pasquale Del Gaudio, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105340-105340
Open Access | Times Cited: 4

Current advances in the therapeutic potential of nanomedicines for pulmonary disorders
Mayank Sharma, Rahul K. Shah, Apeksha Saraf, et al.
Emergent Materials (2024)
Closed Access | Times Cited: 4

Rifampicin-loaded phthalated cashew gum nano-embedded microparticles intended for pulmonary administration
Joandra Maísa da Silva Leite, Antônia Carla de Jesus Oliveira, Douglas Dourado, et al.
International Journal of Biological Macromolecules (2025) Vol. 303, pp. 140693-140693
Closed Access

Understanding dry proteins and their protection with solid‐state hydrogen–deuterium exchange
Julia A. Brom, Gary J. Pielak
Protein Science (2025) Vol. 34, Iss. 3
Closed Access

Advancements in the Design and Development of Dry Powder Inhalers and Potential Implications for Generic Development
Abhinav Ram Mohan, Qiang Wang, Sneha Dhapare, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2495-2495
Open Access | Times Cited: 16

Excipients for Novel Inhaled Dosage Forms: An Overview
Carol Yousry, Mimansa Goyal, Vivek Gupta
AAPS PharmSciTech (2024) Vol. 25, Iss. 2
Closed Access | Times Cited: 3

Efficacy and Mechanisms of Natural Products as Therapeutic Interventions for Chronic Respiratory Diseases
Fanli Jin, Pengbei Fan, Yuanyuan Wu, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 01, pp. 57-88
Closed Access | Times Cited: 3

Formulation strategies, preparation methods, and devices for pulmonary delivery of biologics
Kai Berkenfeld, Simone Pinto Carneiro, Carolina Corzo, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 204, pp. 114530-114530
Open Access | Times Cited: 3

Pulmonary drug delivery technology enables anakinra repurposing in cystic fibrosis
Matteo Puccetti, Marilena Pariano, Claudia Stincardini, et al.
Journal of Controlled Release (2022) Vol. 353, pp. 1023-1036
Closed Access | Times Cited: 14

Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements
Sabrina Magramane, Kristina Vlahović, Peter G. Gordon, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1658-1658
Open Access | Times Cited: 8

Development of an inhalable antiviral powder formulation against respiratory syncytial virus
Rick Heida, Renate Akkerman, Paulo Jacob Silva, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 264-273
Open Access | Times Cited: 6

High-loading cannabidiol powders for inhalation
Waiting Tai, Grace Tsz Yan Yau, Jonathon C. Arnold, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124370-124370
Open Access | Times Cited: 2

Influence of L-leucine content on the aerosolization stability of spray-dried protein dry powder inhalation (DPI)
Johanna Dieplinger, Andreina Isabel Afonso Urich, Nila Mohsenzada, et al.
International Journal of Pharmaceutics (2024) Vol. 666, pp. 124822-124822
Closed Access | Times Cited: 2

Pirfenidone microcrystals for pulmonary delivery: Regulation of the precipitation behavior in the supercooled droplet
Kangwei Lu, Shen Yan, B. H. Li, et al.
International Journal of Pharmaceutics (2024) Vol. 669, pp. 125074-125074
Closed Access | Times Cited: 2

Spray Dried Rugose Lipid Particle Platform for Respiratory Drug Delivery
Hui Wang, Mani Ordoubadi, Patrick Connaughton, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 4, pp. 805-823
Closed Access | Times Cited: 10

Quality by design – Spray drying of ciprofloxacin-quercetin fixed-dose combination intended for inhalation
Nasser Alhajj, Niall J. O’Reilly, Helen Cathcart
International Journal of Pharmaceutics (2023) Vol. 642, pp. 123151-123151
Open Access | Times Cited: 5

Engineering Inhalable Therapeutic Particles: Conventional and Emerging Approaches
Aditi Negi, Shubham Nimbkar, J.A. Moses
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2706-2706
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top